NASDAQ: THTX - Theratechnologies Inc.

六个月盈利: -4.41%
部门: Healthcare

促销时间表 Theratechnologies Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, a recombinant humanized monoclonal antibody, which is an injection for the treatment of multidrug resistant HIV-1 infected patients.

更多详情
Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; and TH1902, which is in Phase 1 clinical trials for the treatment of various solid tumors, including HR+ breast cancer, triple negative breast cancer, ovarian cancer, endometrial cancer, melanoma, thyroid cancer, small cell lung cancer, and prostate cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Выручка 0.0632
EBITDA 4.0E-5
Число акций ао 0.02633 млрд
P/S 3.85
P/BV 9.79
EV/EBITDA 6629.33
Цена ао 1.41
ISIN CA88338H1001
Сайт https://www.theratech.com
Валюта usd
IPO date 2016-01-04
Sector Health Care
Industry Biotechnology
Валюта отчета usd
每日价格变化: 0% (1.3)
每周价格变化: +6.56% (1.22)
每月价格变化: -3.7% (1.35)
3个月内价格变化: -15.58% (1.54)
六个月内的价格变化: -4.41% (1.36)
每年价格变化: -21.21% (1.65)
3年内价格变化: -63.38% (3.55)
5年内价格变化: -69.19% (4.22)
年初以来价格变化: -2.26% (1.33)
所有参数

低估

姓名 意义 年级
P/S 0.4638 10
P/BV -1.82 0
P/E 0 0
EV/EBITDA -8.33 0
全部的: 4.75

效率

姓名 意义 年级
ROA, % -30.81 0
ROE, % 114.79 10
全部的: 3.33

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -7.75 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % 29.37 4
盈利能力 Ebitda, % -18947.5 0
盈利能力 EPS, % 457.81 10
全部的: 4.8
更多详情

机构 体积 分享, %
Nantahala Capital Management, LLC 5364456 11.67
Soleus Capital Management, L.P. 4801376 10.44
AIGH Capital Management LLC 3719302 8.09
Morgan Stanley 2259400 4.91
Worth Venture Partners, LLC 906557 1.97
Osaic Holdings Inc 128054 0.28
National Bank of Canada/FI 113378 0.25
Cyndeo Wealth Partners, LLC 104120 0.23
Stifel Financial Corporation 69058 0.15
Wealthspire Advisors, LLC 51250 0.11



导师 职称 支付 出生年份
Mr. Paul Lévesque President, CEO & Director 1.18M 1964 (60 年)
Mr. Philippe Dubuc M.B.A., MBA Senior VP & CFO 432.31k 1967 (57 年)
Mr. Jocelyn Lafond L.L.M., LL.B. General Counsel & Corporate Secretary 316.29k 1968 (56 年)
Dr. Christian Marsolais Ph.D. Senior VP & Chief Medical Officer 434.61k 1963 (61 年)
Mr. John Leasure Global Commercial Officer 420.91k 1965 (59 年)
Hon. Andre Dupras M.Sc. Vice President of Human Resources N/A 1964 (60 年)

地址: Canada, Montreal. QC HA T, 2015 Peel Street - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.theratech.com